BioWorld MedTech

Aug. 5, 2011

Medtronic recruits Yale to review Infuse clinical trials

Medtronic (Minneapolis) reported that it is funding two independent reviews of studies of its Infuse bone graft in the wake of criticism of the clinical trials it conducted to support the device. (Medical Device Daily) Read More

Need to check your glucose? There may be an app for that

International report: Misonix enters 3-year product distribution agreement in Taiwan

Deals roundup: Emdeon enters into $3 billion merger with Blackstone Capital

Financings roundup: NeoChord raises $5M, seeks $11M for mitral regurgitation treatment

MDD's food for med-tech thought

Agreements/contracts: LABSCO to distribute systems and test kits for Diamedix

HIT roundup: ActiveCare device monitors vital signs for seniors

Product Briefs

Med-Tech Notes

People in the News

MDD's Diagnostic Extra

Today's news in brief

BioWorld

BioWorld briefs for May 22, 2026.

Acid alpha-glucosidase molecular structure isolated on black

‘Detargeted’ targeted gene therapy improves activity in Pompe

BioWorld

A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...

Roche reports new TREM2 agonists

BioWorld Science

F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...

Genescience presents STAT6 degrader for atopic dermatitis

BioWorld Science

Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....

Sangamo presents primate data for prion suppressor ST-506

BioWorld Science

Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...